Adlai Nortye Ltd.
ANLNasdaqHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Clinical trials
ClinicalTrials.gov · ongoing · next readout first- Phase 1Active Not Recruitingreadout ~2024-05-31AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
- Phase 1Recruitingreadout ~2026-11First in Human, Dose Escalation Study of AN4005
- Phase 1Recruitingreadout ~2028-01-31Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Cormorant Asset Management, LpPassive (13G)May 15, 2026
- Hangzhou Jingyin Investment PartnershipPassive (13G)May 14, 2026
- Venrock Healthcare Capital Partners Iii, L.P.Passive (13G)Feb 11, 2026
- Unique Mark Ventures LtdPassive (13G)Feb 9, 2026
- Anl Talent LtdPassive (13G)Jan 16, 2026
- Boary Investment Co. Ltd.Passive (13G)Apr 29, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.1M | 15.4 | +4.5% |
| Apr 30, 2026 | 2.9M | 4.4 | +28.2% |
| Apr 15, 2026 | 2.3M | 3.1 | +82.5% |
| Mar 31, 2026 | 1.3M | 7.5 | +18.1% |
| Mar 13, 2026 | 1.1M | 5.5 | +27.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 3PRIMARY DOCUMENTJun 1, 2026
- 3PRIMARY DOCUMENTMay 28, 2026
- 4PRIMARY DOCUMENTMay 21, 2026
- 3PRIMARY DOCUMENTMay 21, 2026
- 3PRIMARY DOCUMENTMay 20, 2026
- SCHEDULE 13GMay 15, 2026
- SCHEDULE 13G/AMay 14, 2026
- 3/APRIMARY DOCUMENTMay 14, 2026
- 3/APRIMARY DOCUMENTMay 8, 2026
- 3PRIMARY DOCUMENTMay 8, 2026
- 3PRIMARY DOCUMENTApr 29, 2026
- EFFECTApr 28, 2026
- CORRESPApr 24, 2026
- F-3/AAMENDMENT NO. 2 TO FORM F-3Apr 24, 2026
- F-3/AAMENDMENT NO. 1 TO FORM F-3Apr 23, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.